Grading (and Classification) Quick Reference: Hematopoietic System

  • Natasha RekhtmanEmail author
  • Marina K Baine
  • Justin A. Bishop


Follicular lymphoma, WHO Grading System


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Swerdlow S, Campo E, Harris N, et al. WHO classification of tumors of haematopoietic and lymphoid tissues (Revised 4th ed.). Lyon, France: IARC Press; 2017.Google Scholar
  2. 2.
    Malcovati L, Papaemmanuil E, Bowen DT, et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. 2011;118:6239–46.CrossRefGoogle Scholar
  3. 3.
    Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365:1384–95.CrossRefGoogle Scholar
  4. 4.
    Patnaik MM, Hanson CA, Sulai NH, et al. Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts. Blood. 2012;119:5674–7.CrossRefGoogle Scholar
  5. 5.
    Mufti GJ, Bennett JM, Goasguen J, et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica. 2008;93:1712–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Natasha Rekhtman
    • 1
    Email author
  • Marina K Baine
    • 2
  • Justin A. Bishop
    • 3
  1. 1.Department of PathologyMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Department of PathologyYale New Haven Hospital, Yale School of MedicineNew HavenUSA
  3. 3.Department of PathologyUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations